CIK 0001054102 · Non-accelerated filer<br>Smaller reporting company
INTERPACE BIOSCIENCES, INC.
Sign in to watch- Ticker
- IDXG
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222919486
- Phone
- 412-224-6100
- Business address
- WATERVIEW PLAZA, SUITE 310, 2001 ROUTE 46, PARSIPPANY, NJ, 07054
- Former names
- Interpace Diagnostics Group, Inc., PDI INC, PROFESSIONAL DETAILING INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-26 | Kamin Peter 10% owner | Purchase | +2,897 | $3.17 | $9K | 41,808 |
| 2021-01-29 | Gorman Robert J. Director | Grant or award | +12,438 | $4.02 | $50K | 18,759 |
| 2020-12-01 | STOVER JACK E Former officer and director | Grant or award · Stock option (right to buy) | +43,750 | 43,750 | ||
| 2020-12-01 | Burnell Thomas W. President and CEO | Grant or award | +100,000 | 225,000 | ||
| 2020-12-01 | Burnell Thomas W. President and CEO | Grant or award | +125,000 | 225,000 | ||
| 2020-07-29 | Early James Former Chief Financial Officer | Option exercise | +5,000 | 7,125 | ||
| 2020-07-29 | Early James Former Chief Financial Officer | Option exercise · Restricted Stock Units | −5,000 | 0 | ||
| 2020-07-09 | Gorman Robert J. Director | Grant or award · Stock Option (right to buy) | +89,000 | 89,000 | ||
| 2020-07-09 | Gorman Robert J. Director | Grant or award · Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2020-07-09 | SULLIVAN STEPHEN J Director | Grant or award · Stock Option (right to buy) | +29,300 | 29,300 | ||
| 2020-07-09 | Rocca Fortunato R. Director | Grant or award · Stock Option (right to buy) | +28,000 | 28,000 | ||
| 2020-07-09 | KEEGAN JOSEPH D Director | Grant or award · Stock Option (right to buy) | +29,000 | 29,000 | ||
| 2020-03-12 | STOVER JACK E President and CEO | Grant or award | +7,188 | 30,271 | ||
| 2020-01-29 | Knechtel Fred S. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2020-01-29 | Gorman Robert J. Director | Grant or award | +6,321 | $7.91 | $50K | 6,321 |
| 2020-01-29 | Early James Chief Financial Officer | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2020-01-22 | STOVER JACK E President and CEO | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2020-01-22 | Richard Gregory Chief Commerical Officer | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-01-15 | McCarthy Laurence Director | Returned to the company · Series A Convertible Preferred Stock | +270 | 0 | ||
| 2020-01-15 | McCarthy Laurence Director | Grant or award · Series B Convertible Preferred Stock | +27,000 | 27,000 |
Page 3 of 8 · 158 trades